Table 4.
HIV-1-Specific Antibodies Detected in CVL By ECL-WB
| |
gp160 |
gp120 |
p66 |
p55 |
p51 |
gp41 |
p31 |
p24 |
p17 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IgG | IgA | IgG | IgA | IgG | IgA | IgG | IgA | IgG | IgA | IgG | IgA | IgG | IgA | IgG | IgA | IgG | IgA | |
| HIV-1 infected subjects | ||||||||||||||||||
| 1 | – | – | – | – | 1.0 | – | – | – | 1.0 | – | – | – | – | – | 1.0 | – | 1.0 | – |
| 2 | 3.0 | 2.0 | 3.0 | 1.0 | 3.0 | 1.0 | 1.0 | – | 3.0 | 1.0 | 3.0 | 1.0 | 2.0 | – | 3.0 | 2.0 | 3.0 | 1.0 |
| 3 | 3.0 | – | 3.0 | – | 2.0 | – | – | – | 2.0 | – | 2.0 | – | 1.0 | – | 3.0 | – | 1.0 | – |
| 4 | 1.0 | – | – | – | 2.0 | – | 2.0 | – | – | – | – | – | – | – | 3.0 | – | 2.0 | – |
| 5 | 1.0 | – | 1.0 | – | 1.0 | – | – | – | – | – | – | – | 1.0 | – | – | – | 1.0 | – |
| 6 | 3.0 | – | 3.0 | – | 3.0 | – | – | – | 3.0 | – | 3.0 | – | – | – | 3.0 | – | 3.0 | – |
| 7 | 3.0 | – | 3.0 | – | 1.0 | – | 1.0 | – | 1.0 | – | 3.0 | – | 2.0 | – | 3.0 | 1.0 | 1.0 | – |
| 8 | 3.0 | – | 3.0 | – | 2.0 | – | – | – | 2.0 | – | 3.0 | – | 1.0 | – | 1.0 | – | 1.0 | – |
| 9 | 3.0 | – | 3.0 | – | 2.0 | – | – | – | – | – | 1.0 | – | – | – | 2.0 | – | 1.0 | – |
| 10 | 1.0 | – | 1.0 | – | 1.0 | – | – | – | – | – | – | – | – | – | 1.0 | – | – | – |
| 11 | 3.0 | – | 2.0 | – | 3.0 | – | – | – | 3.0 | – | 2.0 | – | 2.0 | – | 3.0 | – | 3.0 | – |
| 12 | 3.0 | – | 3.0 | – | 3.0 | – | – | – | 3.0 | – | 3.0 | – | 2.0 | – | 3.0 | – | 3.0 | 2.0 |
| 13 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.0 | – | 1.0 | – |
| 14 | 2.0 | – | – | – | 2.0 | – | – | – | 2.0 | – | – | – | 1.0 | – | 2.0 | – | 1.0 | – |
| 15 | 2.0 | 1.0 | 1.0 | – | 2.0 | 2.0 | 1.0 | – | 2.0 | 2.0 | 2.0 | 2.0 | 1.0 | 3.0 | 3.0 | 3.0 | 1.0 | 1.0 |
| 16 | 1.0 | – | – | – | 1.0 | – | – | – | – | – | – | – | – | – | 1.0 | – | – | – |
| 17 | 2.0 | – | 1.0 | – | 2.0 | – | 1.0 | – | 2.0 | – | 2.0 | – | – | – | 3.0 | 2.0 | 2.0 | – |
| 18 | 1.0 | – | – | – | 2.0 | – | – | – | 2.0 | – | – | – | 2.0 | – | 3.0 | – | 1.0 | – |
| 19 | 3.0 | – | 3.0 | – | 2.0 | – | – | – | 2.0 | – | 3.0 | – | 2.0 | – | 3.0 | – | 2.0 | – |
| 20 | 1.0 | – | – | – | 1.0 | – | – | – | – | – | – | – | 1.0 | – | 2.0 | – | 1.0 | – |
| 21 | 2.0 | – | 2.0 | – | 2.0 | – | – | – | 2.0 | – | 1.0 | – | 1.0 | – | 3.0 | – | 3.0 | – |
| 22 | 3.0 | – | 3.0 | – | 3.0 | 1.0 | 2.0 | – | 3.0 | 1.0 | 3.0 | – | 3.0 | 1.0 | 3.0 | 3.0 | 3.0 | – |
| 23 | 1.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.0 | – | – | – |
| 24 | 2.0 | – | 1.0 | – | 2.0 | – | – | – | 1.0 | – | 2.0 | – | – | – | 3.0 | 1.0 | 3.0 | – |
| 25 | 3.0 | – | 2.0 | – | 1.0 | – | – | – | – | – | 1.0 | – | 1.0 | – | 1.0 | – | – | – |
| 26 | 1.0 | – | – | – | 1.0 | – | – | – | 1.0 | – | 2.0 | – | – | – | 1.0 | – | 1.0 | – |
| HEPSN subjects | ||||||||||||||||||
| 1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 5 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.0 | – | – | – |
| 7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 9 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 10 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 11 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 12 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 13 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 14 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 15 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 16 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 17 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 18 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 19 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.0 | – | – | – |
| 20 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 21 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 22 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 23 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 24 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 25 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 26 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 27 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 28 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 29 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.0 |
| 30 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 31 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 32 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 33 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 34 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 35 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 36 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 37 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 38 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 39 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 40 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 41 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Assays were performed in Laboratory A as described in the Materials and Methods. Shown is the relative intensity of bands reacting with viral proteins, with greatest intensity indicated by a value of 3.0. Dashes denote the samples that were negative.